chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Influenza like illness, Mass
Clinical narrative: egg shape bump on arm; flu like sympotoms; fever , <100F; headache; chills; nausea; fatigue; fever , <100F; headache; chills; nausea; fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of the first episode of PYREXIA (fever , <100F), the first episode of HEADACHE (headache), the first episode of CHILLS (chills), the first episode of NAUSEA (nausea) and the first episode of FATIGUE (fatigue) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CLONAZEPAM, PRAMIPEXOLE and GABAPENTIN for an unknown indication.    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 24-Feb-2021, the patient experienced the first episode of PYREXIA (fever , <100F), the first episode of HEADACHE (headache), the first episode of CHILLS (chills), the first episode of NAUSEA (nausea) and the first episode of FATIGUE (fatigue). On 23-Mar-2021, the patient experienced the second episode of PYREXIA (fever , <100F), the second episode of HEADACHE (headache), the second episode of CHILLS (chills), the second episode of NAUSEA (nausea) and the second episode of FATIGUE (fatigue). On an unknown date, the patient experienced MASS (egg shape bump on arm) and INFLUENZA LIKE ILLNESS (flu like sympotoms). On 24-Mar-2021, last episode of PYREXIA (fever , <100F), the last episode of HEADACHE (headache), the last episode of CHILLS (chills), the last episode of NAUSEA (nausea) and the last episode of FATIGUE (fatigue) had resolved. At the time of the report, MASS (egg shape bump on arm) and INFLUENZA LIKE ILLNESS (flu like sympotoms) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The Treatment information was not provided.   This case was linked to MOD-2021-093096 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: New events added.FU for both Dose Case On 27-May-2021: FU of second dose case
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: egg shape bump on arm; flu like sympotoms; fever , <100F; headache; chills; nausea; fatigue; fever , <100F; headache; chills; nausea; fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of the first episode of PYREXIA (fever , <100F), the first episode of HEADACHE (headache), the first episode of CHILLS (chills), the first episode of NAUSEA (nausea) and the first episode of FATIGUE (fatigue) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CLONAZEPAM, PRAMIPEXOLE and GABAPENTIN for an unknown indication.    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 24-Feb-2021, the patient experienced the first episode of PYREXIA (fever , <100F), the first episode of HEADACHE (headache), the first episode of CHILLS (chills), the first episode of NAUSEA (nausea) and the first episode of FATIGUE (fatigue). On 23-Mar-2021, the patient experienced the second episode of PYREXIA (fever , <100F), the second episode of HEADACHE (headache), the second episode of CHILLS (chills), the second episode of NAUSEA (nausea) and the second episode of FATIGUE (fatigue). On an unknown date, the patient experienced MASS (egg shape bump on arm) and INFLUENZA LIKE ILLNESS (flu like sympotoms). On 24-Mar-2021, last episode of PYREXIA (fever , <100F), the last episode of HEADACHE (headache), the last episode of CHILLS (chills), the last episode of NAUSEA (nausea) and the last episode of FATIGUE (fatigue) had resolved. At the time of the report, MASS (egg shape bump on arm) and INFLUENZA LIKE ILLNESS (flu like sympotoms) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The Treatment information was not provided.   This case was linked to MOD-2021-093096 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: New events added.FU for both Dose Case On 27-May-2021: FU of second dose case
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Blindness, Dizziness, Headache, Migraine with aura, Photopsia
Clinical narrative: Slightly odd, maybe dizzy; headache; Migraine with aura; Light flashes; Sudden loss of vision; foggy vision; migraine with aura; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE WITH AURA (migraine with aura), PHOTOPSIA (Light flashes), BLINDNESS (Sudden loss of vision), VISION BLURRED (foggy vision) and MIGRAINE WITH AURA (Migraine with aura) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021 at 11:00 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MIGRAINE WITH AURA (migraine with aura). On 27-Apr-2021, the patient experienced PHOTOPSIA (Light flashes), BLINDNESS (Sudden loss of vision) and VISION BLURRED (foggy vision). On 04-May-2021 at 2:30 PM, the patient experienced MIGRAINE WITH AURA (Migraine with aura). On an unknown date, the patient experienced DIZZINESS (Slightly odd, maybe dizzy) and HEADACHE (headache). The patient was treated with IBUPROFEN for Headache, at a dose of UNK, bid. On 17-Apr-2021, MIGRAINE WITH AURA (migraine with aura) had resolved. On 04-May-2021, MIGRAINE WITH AURA (Migraine with aura) had resolved. At the time of the report, PHOTOPSIA (Light flashes), BLINDNESS (Sudden loss of vision), VISION BLURRED (foggy vision), DIZZINESS (Slightly odd, maybe dizzy) and HEADACHE (headache) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medication were reported.  Patient reported of being nearsighted and wears usual glasses.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Added patient's demographics, treatment drug and events(migraine with aura, dizziness and headache). Updated outcome of events from unknown to resolved. On 19-Jul-2021: FU Received - No new information was received.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Slightly odd, maybe dizzy; headache; Migraine with aura; Light flashes; Sudden loss of vision; foggy vision; migraine with aura; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE WITH AURA (migraine with aura), PHOTOPSIA (Light flashes), BLINDNESS (Sudden loss of vision), VISION BLURRED (foggy vision) and MIGRAINE WITH AURA (Migraine with aura) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021 at 11:00 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MIGRAINE WITH AURA (migraine with aura). On 27-Apr-2021, the patient experienced PHOTOPSIA (Light flashes), BLINDNESS (Sudden loss of vision) and VISION BLURRED (foggy vision). On 04-May-2021 at 2:30 PM, the patient experienced MIGRAINE WITH AURA (Migraine with aura). On an unknown date, the patient experienced DIZZINESS (Slightly odd, maybe dizzy) and HEADACHE (headache). The patient was treated with IBUPROFEN for Headache, at a dose of UNK, bid. On 17-Apr-2021, MIGRAINE WITH AURA (migraine with aura) had resolved. On 04-May-2021, MIGRAINE WITH AURA (Migraine with aura) had resolved. At the time of the report, PHOTOPSIA (Light flashes), BLINDNESS (Sudden loss of vision), VISION BLURRED (foggy vision), DIZZINESS (Slightly odd, maybe dizzy) and HEADACHE (headache) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable. No concomitant medication were reported.  Patient reported of being nearsighted and wears usual glasses.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Added patient's demographics, treatment drug and events(migraine with aura, dizziness and headache). Updated outcome of events from unknown to resolved. On 19-Jul-2021: FU Received - No new information was received.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Eye pruritus, Gingival blister, Pruritus, Rash erythematous
Clinical narrative: Red Dots all over the Body; Swell Up Red Dot area; Blisters on Foot, and Finger; Blisters on Gums; itching local; Redness local; Red/itchy eyes; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red Dots all over the Body), SWELLING (Swell Up Red Dot area), RASH ERYTHEMATOUS (Redness local), EYE PRURITUS (Red/itchy eyes) and BLISTER (Blisters on Foot, and Finger) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stent placement on 27-Mar-2020. Concomitant products included CLOPIDOGREL for Anticoagulant therapy, CARVEDILOL and OLMESARTAN for Blood pressure high, ATORVASTATIN for Cholesterol, PANTOPRAZOLE for Indigestion, LEVOTHYROXINE for Thyroid disorder NOS.   On 05-Feb-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Redness local), EYE PRURITUS (Red/itchy eyes) and PRURITUS (itching local). On 21-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Red Dots all over the Body), SWELLING (Swell Up Red Dot area), BLISTER (Blisters on Foot, and Finger) and GINGIVAL BLISTER (Blisters on Gums). At the time of the report, RASH ERYTHEMATOUS (Red Dots all over the Body) had not resolved and SWELLING (Swell Up Red Dot area), RASH ERYTHEMATOUS (Redness local), EYE PRURITUS (Red/itchy eyes), BLISTER (Blisters on Foot, and Finger), GINGIVAL BLISTER (Blisters on Gums) and PRURITUS (itching local) outcome was unknown.            No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up received on 03-JUNE-2021 and does not contain any new information. On 09-Jun-2021: Follow up received on 09-JUNE-2021 and does not contain any new information. On 22-Jul-2021: Added patient demographics, concomitant medications and new events.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Red Dots all over the Body; Swell Up Red Dot area; Blisters on Foot, and Finger; Blisters on Gums; itching local; Redness local; Red/itchy eyes; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red Dots all over the Body), SWELLING (Swell Up Red Dot area), RASH ERYTHEMATOUS (Redness local), EYE PRURITUS (Red/itchy eyes) and BLISTER (Blisters on Foot, and Finger) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Stent placement on 27-Mar-2020. Concomitant products included CLOPIDOGREL for Anticoagulant therapy, CARVEDILOL and OLMESARTAN for Blood pressure high, ATORVASTATIN for Cholesterol, PANTOPRAZOLE for Indigestion, LEVOTHYROXINE for Thyroid disorder NOS.   On 05-Feb-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Redness local), EYE PRURITUS (Red/itchy eyes) and PRURITUS (itching local). On 21-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Red Dots all over the Body), SWELLING (Swell Up Red Dot area), BLISTER (Blisters on Foot, and Finger) and GINGIVAL BLISTER (Blisters on Gums). At the time of the report, RASH ERYTHEMATOUS (Red Dots all over the Body) had not resolved and SWELLING (Swell Up Red Dot area), RASH ERYTHEMATOUS (Redness local), EYE PRURITUS (Red/itchy eyes), BLISTER (Blisters on Foot, and Finger), GINGIVAL BLISTER (Blisters on Gums) and PRURITUS (itching local) outcome was unknown.            No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up received on 03-JUNE-2021 and does not contain any new information. On 09-Jun-2021: Follow up received on 09-JUNE-2021 and does not contain any new information. On 22-Jul-2021: Added patient demographics, concomitant medications and new events.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Bedridden, Dizziness, Eating disorder, Fatigue
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), EATING DISORDER (cannot eat), BEDRIDDEN (bed ridden), HEADACHE (headache) and VOMITING (vomiting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LATANOPROST for an unknown indication.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced DIZZINESS (Dizziness), EATING DISORDER (cannot eat), BEDRIDDEN (bed ridden), HEADACHE (headache), FATIGUE (weary) and ASTHENIA (lapse in energy). 28-Apr-2021, the patient experienced VOMITING (vomiting). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DIZZINESS (Dizziness), EATING DISORDER (cannot eat), BEDRIDDEN (bed ridden), HEADACHE (headache), VOMITING (vomiting), FATIGUE (weary) and ASTHENIA (lapse in energy) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), EATING DISORDER (cannot eat), BEDRIDDEN (bed ridden), HEADACHE (headache) and VOMITING (vomiting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LATANOPROST for an unknown indication.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced DIZZINESS (Dizziness), EATING DISORDER (cannot eat), BEDRIDDEN (bed ridden), HEADACHE (headache), FATIGUE (weary) and ASTHENIA (lapse in energy). 28-Apr-2021, the patient experienced VOMITING (vomiting). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DIZZINESS (Dizziness), EATING DISORDER (cannot eat), BEDRIDDEN (bed ridden), HEADACHE (headache), VOMITING (vomiting), FATIGUE (weary) and ASTHENIA (lapse in energy) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: past the recommended window; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (past the recommended window) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (past the recommended window). At the time of the report, PRODUCT DOSE OMISSION ISSUE (past the recommended window) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Confusional state, Dizziness, Headache, Myalgia
Clinical narrative: Severe arm soreness; Fever; Headache; Shivers; Body aches; Dizziness; Confusion; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), CONFUSIONAL STATE (Confusion), VACCINATION SITE PAIN (Severe arm soreness), PYREXIA (Fever) and HEADACHE (Headache) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced DIZZINESS (Dizziness), CONFUSIONAL STATE (Confusion), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Shivers) and MYALGIA (Body aches). On an unknown date, the patient experienced VACCINATION SITE PAIN (Severe arm soreness). The patient was treated with PARACETAMOL (TYLENOL) for Headache, Vaccination site pain, Fever, Shivers and Myalgia, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), CONFUSIONAL STATE (Confusion), VACCINATION SITE PAIN (Severe arm soreness), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Shivers) and MYALGIA (Body aches) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Severe arm soreness; Fever; Headache; Shivers; Body aches; Dizziness; Confusion; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), CONFUSIONAL STATE (Confusion), VACCINATION SITE PAIN (Severe arm soreness), PYREXIA (Fever) and HEADACHE (Headache) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced DIZZINESS (Dizziness), CONFUSIONAL STATE (Confusion), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Shivers) and MYALGIA (Body aches). On an unknown date, the patient experienced VACCINATION SITE PAIN (Severe arm soreness). The patient was treated with PARACETAMOL (TYLENOL) for Headache, Vaccination site pain, Fever, Shivers and Myalgia, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), CONFUSIONAL STATE (Confusion), VACCINATION SITE PAIN (Severe arm soreness), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Shivers) and MYALGIA (Body aches) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration, Vaccination complication, Vaccination site discolouration, Vaccination site erythema
Clinical narrative: COVID arm; Injection site faded to a tan color; redness down the elbow and arm; hardness down the elbow and arm; Injection site Itchy; Arm at injection site hard, down to elbow and lower arm; arm at the injection site was red, down to elbow and lower arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID arm), VACCINATION SITE DISCOLOURATION (Injection site faded to a tan color), ERYTHEMA (redness down the elbow and arm), INDURATION (hardness down the elbow and arm) and VACCINATION SITE PRURITUS (Injection site Itchy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009CZIA and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (COVID arm), VACCINATION SITE DISCOLOURATION (Injection site faded to a tan color), ERYTHEMA (redness down the elbow and arm), INDURATION (hardness down the elbow and arm), VACCINATION SITE PRURITUS (Injection site Itchy), VACCINATION SITE INDURATION (Arm at injection site hard, down to elbow and lower arm) and VACCINATION SITE ERYTHEMA (arm at the injection site was red, down to elbow and lower arm). At the time of the report, VACCINATION COMPLICATION (COVID arm), VACCINATION SITE DISCOLOURATION (Injection site faded to a tan color), ERYTHEMA (redness down the elbow and arm), INDURATION (hardness down the elbow and arm), VACCINATION SITE PRURITUS (Injection site Itchy), VACCINATION SITE INDURATION (Arm at injection site hard, down to elbow and lower arm) and VACCINATION SITE ERYTHEMA (arm at the injection site was red, down to elbow and lower arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information is provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pruritus
Clinical narrative: COVID arm; Injection site faded to a tan color; redness down the elbow and arm; hardness down the elbow and arm; Injection site Itchy; Arm at injection site hard, down to elbow and lower arm; arm at the injection site was red, down to elbow and lower arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID arm), VACCINATION SITE DISCOLOURATION (Injection site faded to a tan color), ERYTHEMA (redness down the elbow and arm), INDURATION (hardness down the elbow and arm) and VACCINATION SITE PRURITUS (Injection site Itchy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009CZIA and 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (COVID arm), VACCINATION SITE DISCOLOURATION (Injection site faded to a tan color), ERYTHEMA (redness down the elbow and arm), INDURATION (hardness down the elbow and arm), VACCINATION SITE PRURITUS (Injection site Itchy), VACCINATION SITE INDURATION (Arm at injection site hard, down to elbow and lower arm) and VACCINATION SITE ERYTHEMA (arm at the injection site was red, down to elbow and lower arm). At the time of the report, VACCINATION COMPLICATION (COVID arm), VACCINATION SITE DISCOLOURATION (Injection site faded to a tan color), ERYTHEMA (redness down the elbow and arm), INDURATION (hardness down the elbow and arm), VACCINATION SITE PRURITUS (Injection site Itchy), VACCINATION SITE INDURATION (Arm at injection site hard, down to elbow and lower arm) and VACCINATION SITE ERYTHEMA (arm at the injection site was red, down to elbow and lower arm) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information is provided.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission in error
Clinical narrative: Missed second dose of Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION IN ERROR (Missed second dose of Moderna vaccine) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Blood pressure. Concomitant products included LISINOPRIL, AMLODIPIN [AMLODIPINE] and METOPROLOL for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PRODUCT DOSE OMISSION IN ERROR (Missed second dose of Moderna vaccine). At the time of the report, PRODUCT DOSE OMISSION IN ERROR (Missed second dose of Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were provided.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Mobility decreased, Myalgia
Clinical narrative: He cannot use hisright hand while using computer, can not hold computer mouse, and can not type; Excruciating pain in all of the patient's joints; pain in any body part that bends including shoulder, elbow, wrist, fingers, ankle, and hips; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Excruciating pain in all of the patient's joints), MYALGIA (pain in any body part that bends including shoulder, elbow, wrist, fingers, ankle, and hips) and MOBILITY DECREASED (He cannot use hisright hand while using computer, can not hold computer mouse, and can not type) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014MWA and 026B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. In April 2021, the patient experienced ARTHRALGIA (Excruciating pain in all of the patient's joints) and MYALGIA (pain in any body part that bends including shoulder, elbow, wrist, fingers, ankle, and hips). On an unknown date, the patient experienced MOBILITY DECREASED (He cannot use hisright hand while using computer, can not hold computer mouse, and can not type). At the time of the report, ARTHRALGIA (Excruciating pain in all of the patient's joints), MYALGIA (pain in any body part that bends including shoulder, elbow, wrist, fingers, ankle, and hips) and MOBILITY DECREASED (He cannot use hisright hand while using computer, can not hold computer mouse, and can not type) had not resolved. Not Provided          no treatment medication were provided  no concomitants were provided
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash
Clinical narrative: little itching; rash located on left side between shoulder and neck around two weeks after/as mosquito bites localized on left side; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), PRURITUS (little itching) and RASH (rash located on left side between shoulder and neck around two weeks after/as mosquito bites localized on left side) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concomitant products included FLUTICASONE, AZELASTINE, SALBUTAMOL (ALBUTEROL HFA) and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm soreness). On 22-Apr-2021, the patient experienced PRURITUS (little itching) and RASH (rash located on left side between shoulder and neck around two weeks after/as mosquito bites localized on left side). On 09-Apr-2021, PAIN IN EXTREMITY (arm soreness) outcome was unknown. At the time of the report, PRURITUS (little itching) and RASH (rash located on left side between shoulder and neck around two weeks after/as mosquito bites localized on left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity
Clinical narrative: Arm pain lasting 4 weeks; difficulty moving the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain lasting 4 weeks) and LIMB DISCOMFORT (difficulty moving the arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (The patient's medical history was not provided.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain lasting 4 weeks) and LIMB DISCOMFORT (difficulty moving the arm). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm pain lasting 4 weeks) and LIMB DISCOMFORT (difficulty moving the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment for the event included ibuprofen (Advil )and ibuprofen (Motrin)   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: itching; Skin eruption; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) and RASH (Skin eruption) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching) and RASH (Skin eruption). At the time of the report, PRURITUS (itching) and RASH (Skin eruption) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Peripheral swelling
Clinical narrative: arm is puffed up and swollen; significant pain in arm and underarm is significantly sore; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm is puffed up and swollen), PAIN IN EXTREMITY (significant pain in arm and underarm is significantly sore) and PAIN (soreness) in a 5-day-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and GABAPENTIN for an unknown indication.    On 25-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021, the patient experienced PERIPHERAL SWELLING (arm is puffed up and swollen), PAIN IN EXTREMITY (significant pain in arm and underarm is significantly sore) and PAIN (soreness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (arm is puffed up and swollen), PAIN IN EXTREMITY (significant pain in arm and underarm is significantly sore) and PAIN (soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.      Treatment details included paracetamol and ibuprofen. Upon internal review on 21 Jun 2021, the patient age is captured as unknown due to unclear information in source document.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Pyrexia
Clinical narrative: fever of 100.9 F; Chill; pain in left hand; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in left hand), PYREXIA (fever of 100.9 F) and CHILLS (Chill) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 009C21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in left hand). On 28-Apr-2021, the patient experienced PYREXIA (fever of 100.9 F) and CHILLS (Chill). On 31-Mar-2021, PAIN IN EXTREMITY (pain in left hand) had resolved. At the time of the report, PYREXIA (fever of 100.9 F) and CHILLS (Chill) outcome was unknown. Not Provided         This case was linked to US-MODERNATX, INC.-MOD-2021-095068 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-095068:Case for dose 2
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Skin disorder
Clinical narrative: Giant patch on head, getting bigger; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISORDER (Giant patch on head, getting bigger) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No medical history was reported by the physician.  Concomitant products included DICLOFENAC SODIUM for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced SKIN DISORDER (Giant patch on head, getting bigger). At the time of the report, SKIN DISORDER (Giant patch on head, getting bigger) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medication include Flexeril  Treatment medication was not provided
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot
Clinical narrative: Redness/size of quarter and now it is size of hand; Hot and warm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness/size of quarter and now it is size of hand) and FEELING HOT (Hot and warm) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced ERYTHEMA (Redness/size of quarter and now it is size of hand) and FEELING HOT (Hot and warm). At the time of the report, ERYTHEMA (Redness/size of quarter and now it is size of hand) and FEELING HOT (Hot and warm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: inappropriate age at vaccine administration; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inappropriate age at vaccine administration) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inappropriate age at vaccine administration). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (inappropriate age at vaccine administration) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: lymph node swelling under arm of side that had received the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph node swelling under arm of side that had received the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (lymph node swelling under arm of side that had received the vaccine). At the time of the report, LYMPHADENOPATHY (lymph node swelling under arm of side that had received the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue, Influenza like illness, Palpitations, Pyrexia
Clinical narrative: heart palpitation; chest tightness; flu like symptoms; lost 8lbs; fever; has no energy, has only been able to go from bed to couch; This spontaneous case was reported by a physician and describes the occurrence of PALPITATIONS (heart palpitation), CHEST DISCOMFORT (chest tightness), INFLUENZA LIKE ILLNESS (flu like symptoms), WEIGHT DECREASED (lost 8lbs) and PYREXIA (fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced PALPITATIONS (heart palpitation), INFLUENZA LIKE ILLNESS (flu like symptoms), WEIGHT DECREASED (lost 8lbs), PYREXIA (fever) and FATIGUE (has no energy, has only been able to go from bed to couch). 16-Apr-2021, the patient experienced CHEST DISCOMFORT (chest tightness). At the time of the report, PALPITATIONS (heart palpitation), CHEST DISCOMFORT (chest tightness), INFLUENZA LIKE ILLNESS (flu like symptoms), WEIGHT DECREASED (lost 8lbs), PYREXIA (fever) and FATIGUE (has no energy, has only been able to go from bed to couch) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Negative) negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. Treatment included  drinking water and juice, getting at least 12 cups of water a day and taking Tylenol for fever.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Weight decreased
Clinical narrative: heart palpitation; chest tightness; flu like symptoms; lost 8lbs; fever; has no energy, has only been able to go from bed to couch; This spontaneous case was reported by a physician and describes the occurrence of PALPITATIONS (heart palpitation), CHEST DISCOMFORT (chest tightness), INFLUENZA LIKE ILLNESS (flu like symptoms), WEIGHT DECREASED (lost 8lbs) and PYREXIA (fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced PALPITATIONS (heart palpitation), INFLUENZA LIKE ILLNESS (flu like symptoms), WEIGHT DECREASED (lost 8lbs), PYREXIA (fever) and FATIGUE (has no energy, has only been able to go from bed to couch). 16-Apr-2021, the patient experienced CHEST DISCOMFORT (chest tightness). At the time of the report, PALPITATIONS (heart palpitation), CHEST DISCOMFORT (chest tightness), INFLUENZA LIKE ILLNESS (flu like symptoms), WEIGHT DECREASED (lost 8lbs), PYREXIA (fever) and FATIGUE (has no energy, has only been able to go from bed to couch) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Negative) negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. Treatment included  drinking water and juice, getting at least 12 cups of water a day and taking Tylenol for fever.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain in extremity, Peripheral swelling, Pyrexia, Swelling
Clinical narrative: Extreme pain in my left ring finger; injection site arm was swollen; entire left side is swollen from my neck to my toes; Feel like I have a Fever but my body temperature is normal; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Extreme pain in my left ring finger), PERIPHERAL SWELLING (injection site arm was swollen), SWELLING (entire left side is swollen from my neck to my toes) and PYREXIA (Feel like I have a Fever but my body temperature is normal) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C211A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced PAIN IN EXTREMITY (Extreme pain in my left ring finger), PERIPHERAL SWELLING (injection site arm was swollen), SWELLING (entire left side is swollen from my neck to my toes) and PYREXIA (Feel like I have a Fever but my body temperature is normal). At the time of the report, PAIN IN EXTREMITY (Extreme pain in my left ring finger), PERIPHERAL SWELLING (injection site arm was swollen), SWELLING (entire left side is swollen from my neck to my toes) and PYREXIA (Feel like I have a Fever but my body temperature is normal) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Apr-2021, Body temperature: 98.6 f normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Amnesia
Clinical narrative: memory loss; This spontaneous case was reported by a consumer and describes the occurrence of AMNESIA (memory loss) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.     On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced AMNESIA (memory loss). At the time of the report, AMNESIA (memory loss) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.